Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 3 pseudogene 12 (HMGB3P12) is a pseudogene, a DNA segment homologous to the protein-coding HMGB3 gene, but considered nonfunctional as it does not encode a protein. Like other pseudogenes, its sequence is highly similar to its parent gene. While pseudogenes have long been considered "junk DNA," emerging evidence shows some may have regulatory functions (e.g., as competing endogenous RNAs, microRNA decoys, or regulators of mRNA stability for their parent genes or related genes)[1][6]. However, there is no specific published evidence that HMGB3P12 encodes a protein or acts as a direct therapeutic target, nor are there known pharmacological agents that interact with it[3][5]. Its role, if any, would be in gene regulation rather than as a conventional drug target such as a receptor, enzyme, or transporter. Assessment: - HMGB3P12 is not a conventional therapeutic target; it is a non-functional pseudogene, and is not classified as a receptor, enzyme, transporter, or druggable molecule[3][5][6]. - There is no evidence for known biological function, involvement in disease, interacting drugs, or mechanisms of action specific to HMGB3P12. - If searching for a target with therapeutic relevance or drug interaction, this entry is likely incorrect or irrelevant for those purposes[2][3][5][6]. - It fits the general characteristics of a processed pseudogene per HGNC and current genetic and genomic guidelines[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 3 pseudogene 12 (HMGB3P12).